To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.

Ying Lu, PhD
Dr. Lu is designing a novel technique to study cellular reactions called ubiquitination and deubiquitination, which are essential for normal biological processes and are often mutated in cancer. He will examine single molecules in cell extracts, with the goal of gaining insights into the role of these reactions in cancer development and growth.
Project Title: "Single-molecular study of ubiquitination/deubiquitination kinetics in cell extracts"
Institution: Harvard Medical School
Sponsor(s) / Mentor(s): Marc W. Kirschner, PhD
Cancer Type: All cancers
Research Area: Biophysics


